Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureMaha Mo'men, Sameh Saber, Ahmed E. Amer, Hassan A. El‐Kashef
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
openalex
Confidence 95%
datacite
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Mirtazapine, an atypical antidepressant, mitigates lung fibrosis by suppressing NLPR3 inflammasome and fibrosis-related mediators in endotracheal bleomycin rat model
10.1016/j.biopha.2023.114553 · 2023
Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications
10.1177/20420188231222367 · 2024
The multifaceted effects of semaglutide: exploring its broad therapeutic applications
10.1080/20565623.2025.2483607 · 2025
Semaglutide reduces alcohol intake and relapse-like drinking in male and female rats
10.1016/j.ebiom.2023.104642 · 2023
Bleomycin-induced chronic lung damage does not resemble human idiopathic pulmonary fibrosis
10.1164/ajrccm.163.7.2006132 · 2001
Targeting sirtuin 1 to improve metabolism: all you need is NAD(+)?
10.1124/pr.110.003905 · 2012
Niacin ameliorates oxidative stress, inflammation, proteinuria, and hypertension in rats with chronic renal failure
10.1152/ajprenal.00126.2009 · 2009
A new era in the treatment of progressive fibrosing interstitial lung diseases
10.1183/20734735.0259-2024 · 2025
SIRT1 exerts protective effects against paraquat-induced injury in mouse type II alveolar epithelial cells by deacetylating NRF2 in vitro
Confidence 0%
10.3892/ijmm.2016.2503 · 2016
Activation of AMPK/SIRT1/FOXO3a signaling by BMS-477118 (saxagliptin) mitigates chronic colitis in rats: uncovering new anti-inflammatory and antifibrotic roles
2024
E1231/NMN protects against experimental metabolic syndrome: the central role of SIRT1 in modulating AKT/Nrf2/NFκB signaling
2025
Activation of SIRT1 by SRT1720 alleviates dyslipidemia, improves insulin sensitivity and exhibits liver-protective effects in diabetic rats on a high-fat diet: new insights into the SIRT1/Nrf2/NFκB signaling pathway
10.1016/j.ejps.2025.107002 · 2025
Activation of nicotinamide phosphoribosyltransferase protects against unilateral renal ischemia-reperfusion injury via the NAD+/SIRT1/PGC-1α signaling pathway and modulation of NFκB/TNF-α/IL-6
10.1016/j.ejps.2025.107302 · 2025
GLP-1 receptor agonist ameliorates experimental lung fibrosis
10.1038/s41598-020-74912-1 · 2020
Natural compounds for SIRT1-mediated oxidative stress and neuroinflammation in stroke: a potential therapeutic target in the future
10.1155/2022/1949718 · 2022
Combination therapy with pirfenidone and nintedanib in idiopathic pulmonary fibrosis: a systematic review and meta-analysis
10.1016/j.chest.2023.07.1984 · 2023
Combinatorial treatment of idiopathic pulmonary fibrosis using nanoparticles with prostaglandin E and siRNA(s)
10.1016/j.nano.2017.04.005 · 2017
Hyperoside attenuates bleomycin-induced pulmonary fibrosis development in mice
10.3389/fphar.2020.550955 · 2020
Immune mechanisms of pulmonary fibrosis with bleomycin
10.3390/ijms24043149 · 2023
Pexidartinib and nintedanib combination therapy targets macrophage polarization to reverse pulmonary fibrosis: a preclinical study
10.3390/ijms26157570 · 2025
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis
10.1056/nejmoa1402582 · 2014
Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes
10.1007/s00125-010-2028-x · 2011
The importance of interventional timing in the bleomycin model of pulmonary fibrosis
10.1183/13993003.01105-2019 · 2020
Semaglutide alleviates ovary inflammation via the AMPK/SIRT1/NF-κB signaling pathway in polycystic ovary syndrome mice
10.2147/dddt.s484531 · 2024
Comprehensive review of potential drugs with anti-pulmonary fibrosis properties
10.1016/j.biopha.2024.116282 · 2024
Modulation of bleomycin-induced oxidative stress and pulmonary fibrosis by N-acetylcysteine in rats via AMPK/SIRT1/NF-κβ
10.1111/1440-1681.13378 · 2020
Neuroprotective effect of niacin in a rat model of obesity induced by high-fat-rich diet
10.1007/s00210-024-03687-3 · 2025
The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?
10.1016/j.biocel.2007.08.011 · 2008
Alvespimycin exhibits potential anti-TGF-β signaling in the setting of a proteasome activator in rats with bleomycin-induced pulmonary fibrosis: a promising novel approach
10.3390/ph16081123 · 2023
NAD+ metabolism, stemness, the immune response, and cancer
10.1038/s41392-020-00354-w · 2021
Adjunctive therapies in idiopathic pulmonary fibrosis—where do we stand?
10.21037/jtd.2018.11.131 · 2018
Effect of nicotinamide riboside on airway inflammation in COPD: a randomized, placebo-controlled trial
10.1038/s43587-024-00758-1 · 2024
Oxidative stress and inflammation regulation of sirtuins: new insights into common oral diseases
2022
The role of NAD(+) and NAD(+)-boosting therapies in inflammatory response by IL-13
10.3390/ph17020226 · 2024
GLP-1 receptor agonists in heart failure
10.3390/biom15101403 · 2025
The role of different SIRT1-mediated signaling pathways in toxic injury
10.1186/s11658-019-0158-9 · 2019
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis
10.1056/nejmoa1402584 · 2014
Nifuroxazide-loaded cubosomes exhibit an advancement in pulmonary delivery and attenuate bleomycin-induced lung fibrosis by regulating the STAT3 and NF-κB signaling: a new challenge for unmet therapeutic needs
10.1016/j.biopha.2022.112731 · 2022
E1231/SR647 protects against unilateral renal ischemia-reperfusion injury by modulating SIRT1/FOXO3 interactions with Nrf2 and NFκB pathways
10.1016/j.ejps.2025.107099 · 2025
Protective effects of niacin following high fat rich diet: an in-vivo and in-silico study
10.1038/s41598-023-48566-8 · 2023
Coomassie brilliant blue G-250 dye attenuates bleomycin-induced lung fibrosis by regulating the NF-κB and NLRP3 crosstalk: a novel approach for filling an unmet medical need
10.1016/j.biopha.2022.112723 · doi-reference
Refined murine model of idiopathic pulmonary fibrosis
10.3791/68484 · doi-reference
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
10.1038/s41392-024-01931-z · doi-reference
GLP-1RAs regulate lipid metabolism and induce autophagy through AMPK/SIRT1 pathway to improve NAFLD
10.1016/j.prostaglandins.2025.106987 · doi-reference
The expanding role of semaglutide: beyond glycemic control
10.1007/s40200-025-01663-z · doi-reference
Modulation of NF-κB-dependent transcription and cell survival by the SIRT1 deacetylase
10.1038/sj.emboj.7600244 · doi-reference
Exploring the antioxidant properties of semaglutide: a comprehensive review
10.1016/j.jdiacomp.2024.108906 · doi-reference
Effects of glucagon-like peptide-1 receptor agonists on gut microbiota in dehydroepiandrosterone-induced polycystic ovary syndrome mice: compared evaluation of liraglutide and semaglutide intervention
10.2147/dmso.s451129 · doi-reference
Integrated spatial and single-cell transcriptomics reveal PAK kinase as a therapeutic target in fibroblastic foci and dense fibrosis of idiopathic pulmonary fibrosis
10.1183/13993003.00022-2025 · doi-reference
Pulmonary fibrosis: pathogenesis and therapeutic strategies
10.1002/mco2.744 · doi-reference
Semaglutide ameliorates cognition and glucose metabolism dysfunction in the 3xTg mouse model of Alzheimer's disease via the GLP-1R/SIRT1/GLUT4 pathway
10.1016/j.neuropharm.2023.109716 · doi-reference
Glucagon-like peptide-1 (GLP-1) mediates the protective effects of dipeptidyl peptidase IV inhibition on pulmonary hypertension
10.1186/s12929-019-0496-y · doi-reference
Niacin modulates SIRT1-driven signaling to counteract radiation-induced neurocognitive and behavioral impairments
10.3390/ijms26115285 · doi-reference
Glucagon-like peptide 1 signaling inhibits allergen-induced lung IL-33 release and reduces group 2 innate lymphoid cell cytokine production in vivo
10.1016/j.jaci.2017.11.043 · doi-reference
Targeting CD38-dependent NAD(+) metabolism to mitigate multiple organ fibrosis
10.1016/j.isci.2020.101902 · doi-reference